Cost-Effectiveness of Pharmacological Interventions for Smoking Cessation: A Literature Review and a Decision Analytic Analysis
Open Access
- 1 September 2002
- journal article
- review article
- Published by SAGE Publications in Medical Decision Making
- Vol. 22 (1_suppl), 26-37
- https://doi.org/10.1177/027298902237708
Abstract
To evaluate the relative cost-effectiveness of nicotine replacement therapy (NRT) and bupropion SR for smoking cessation, the authors reviewed published studies and developed a decision analytic model from the UK National Health Services perspective. Irrespective of the methods or assumptions involved, the results of published studies consistently indicated that NRT for smoking cessation is cost-effective. No published studies have evaluated the relative cost-effectiveness of bupropion SR for smoking cessation. The results of the decision analyses indicated that, as compared with advice or counseling alone, the incremental cost per life-years saved is about $1,441~$3,455 for NRT, $920~$2,150 for bupropion SR, and $1,282~$2,836 for NRT plus bupropion SR. The cost-effectiveness of adding NRT and bupropion SR to advice or counseling for smoking cessation is better than many other accepted health care interventions.Keywords
This publication has 22 references indexed in Scilit:
- Development of the health and economic consequences of smoking interactive modelTobacco Control, 2001
- Smoking vs Other Risk Factors as the Cause of Smoking-Attributable DeathsPublished by American Medical Association (AMA) ,2000
- Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studiesBMJ, 2000
- Pharmacotherapy of nicotine dependenceInternational journal of clinical pharmacology and therapeutics, 2000
- Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectivenessThe Lancet, 1999
- Recent Advances in the Pharmacotherapy of SmokingJama-Journal Of The American Medical Association, 1999
- Costs and effects associated with a community pharmacy-based smoking-cessation programme.PharmacoEconomics, 1998
- Cost-effectiveness of the Clinical Practice Recommendations in the AHCPR Guideline for Smoking CessationPublished by American Medical Association (AMA) ,1997
- The Cost-Effectiveness of the Nicotine Transdermal Patch for Smoking CessationPreventive Medicine, 1997
- Mortality in relation to smoking: 40 years' observations on male British doctorsBMJ, 1994